Co-occurrence of KRAS G12D and Mutant TP53 Predicts Improved Outcome in Surgically Resected Pancreatic Ductal Adenocarcinoma. (2022) - Shoucair, S.; Habib, J.; Pu, N.; Kinny-Köster, B.; Javed, A.; Lafaro, K.; He, J.; Wolfgang, C.; Yu, J.